Decoding the Effects of Bexarotene treatment on brain of AD-like model mice: Single-Cell Transcriptomics and

Yi Lu1, Xuebao Wang1, Carolina Saibro-Girardi1

  • 1University of Pittsburgh.

Research Square
|August 20, 2025
PubMed
Abstract

Insights

Retinoid X Receptor (RXR) activation by Bexarotene modulates gene networks critical for brain health, potentially offering new therapeutic avenues for neurodegenerative diseases by restoring homeostasis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genomics

Background:

  • Ligand-activated Retinoid X Receptors (RXRs) are crucial for neural development, neuroinflammation, and metabolism.
  • Understanding RXR's influence on chromatin and gene expression is key for treating neurodegenerative diseases.

Purpose of the Study:

  • To investigate RXR-mediated regulatory mechanisms in a mouse model of Alzheimer's disease.
  • To elucidate the epigenomic and transcriptional effects of RXR activation.

Main Methods:

  • Integrated single-nucleus ATAC-seq (snATAC-seq) and single-cell RNA-seq (scRNA-seq).
  • Validated chromatin accessibility with RXR ChIP-seq.
  • Performed transcription factor (TF) footprinting to map RXR-activated regulatory networks.

Main Results:

  • Identified a multilayered transcriptional cascade initiated by RXR signaling.
  • Revealed RXR-centered circuits involving TF heterodimer activation and metabolic pathway induction.
  • Bexarotene modulates existing TF networks rather than dismantling neuronal regulatory scaffolds.

Conclusions:

  • Integrated omics approaches provide comprehensive analysis of RXR transcriptional regulation.
  • RXR activation orchestrates gene networks to restore brain homeostasis in disease contexts.

Related Concept Videos